| Old Articles: <Older 931-940 Newer> |
|---|
 |
Geotimes
March 2006
Bergstrom & Lipsitch |
Evolution Lessons From Infectious Diseases Even though the critics of evolutionary biology rarely dispute examples of microbial evolution on human timescales, the public appears largely unaware of the importance and success of evolutionary biology in dealing with human disease.   |
IEEE Spectrum
March 2006
Samuel K. Moore |
Psychiatry's Shocking New Tools Electronic implants and electromagnetic pulses are picking up where psychoactive drugs have failed. |
Chemistry World
February 27, 2006
Michael Gross |
A DNA Switch for RNA Folding Researchers have equipped a large RNA domain with a DNA switch, which they say can fold or unfold the RNA molecule at will. |
Scientific American
February 27, 2006
Charles Q. Choi |
Going to Bat Long known as vectors for rabies, bats may be the origin of some of the most deadly emerging viruses. Knowledge that bats can carry dangerous viruses could work to prevent epidemics. |
Bio-IT World
February 2006
John Russell |
Marvelous Models of Biological Systems Here are highlights from a roundtable discussion with researchers representing academia and pharmaceuticals, as well as executives from modeling technology providers on whether or not Pharma is ready to bet on computational modeling of biological systems. |
Bio-IT World
February 2006
Nancy Weil |
The Evolving Boon of Bioinformatics As the heady days of cracking the human genome gave way to day-to-day work on a plethora of new drug targets, many bioinformaticians have reached a career crossroads, going to work for major consultancies, starting their own such small firms, or switching to academia. |
Bio-IT World
February 2006
Graeme O'Neill |
GTG Celebrates Win Over Applera America's largest gene-testing company Applera agreed to license Australia's GTG's patented "junk DNA" gene-testing technology after a three-year battle. Applera will pay GTG about $11 million in the form of cash, equipment, and intellectual property. |
Bio-IT World
February 2006
John Russell |
Inside BG Medicine Think Intel Inside, but instead of microprocessors, think industrial-strength experimental platforms, focused on all things omic, designed and even run by a third party, but living deep inside biopharmaceutical companies. This is BM Medicine's CEO Pieter Muntendam's strategy. |
Bio-IT World
February 2006
Kevin Davies |
The Cancer Genome Atlas Pilot Launches Researchers from the National Cancer Institute and the National Human Genome Research Institute announced the launch of a three-year, $100 million pilot program for the Human Cancer Genome Project. |
Bio-IT World
February 2006
Mark D. Uehling |
Pharma's Mixed Response to Trials Database A late December New England Journal of Medicine article detailed Big Pharma's response to mandatory registration of clinical trials. Here are some highlights. |
| <Older 931-940 Newer> Return to current articles. |
